Evidence map›Paper›PMID 21139074›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2011

β-Arrestin mediates oxytocin receptor signaling, which regulates uterine contractility and cellular migration.

Chad A Grotegut, Liping Feng, Lan Mao, R Phillips Heine, Amy P Murtha, Howard A Rockman

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. G Protein-coupled Receptor Biased Agonism.Journal of cardiovascular pharmacology · 2016
    Review
  14. Article
  15. Review
  16. Article
  17. Osteoblast regulation via ligand-activated nuclear trafficking of the oxytocin receptor.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Chad A GrotegutDiv. of Maternal-Fetal Medicine, Dept. of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC 27710, USA. chad.grotegut@duke.edu
Liping Feng
Lan Mao
R Phillips Heine
Amy P Murtha
Howard A Rockman
Beijing Obstetrics and Gynecology Hospital · CNDuke University · US

Funding

Interdisciplinary Research Careers in Women's HealthK12HD043446 · NICHD · DUKE UNIVERSITY · PI AMUNDSEN, CINDY · 2002 to 2023
$9.6M
NICHD NIH HHS K12-HD-043446
6 · The paper itself

Abstract

Desensitization of the oxytocin receptor (OXTR) in the setting of prolonged oxytocin exposure may lead to dysfunctional labor, which increases the risk for cesarean delivery, and uterine atony, which may result in postpartum hemorrhage. The molecular mechanism for OXTR desensitization is through the agonist-mediated recruitment of the multifunctional protein β-arrestin. In addition to its desensitizing function, β-arrestins have recently been shown to simultaneously activate downstream signaling. We tested whether oxytocin stimulation promotes β-arrestin-mediated OXTR desensitization in vivo and activates β-arrestin-mediated mitogen-activated protein kinase (MAPK) growth signaling. Uterine muscle strips isolated from wild-type mice exhibited diminished uterine contractility following repeated exposure to oxytocin, whereas uterine muscle strips from β-arrestin-1 and β-arrestin-2 knockout mice showed no desensitization. Utilizing siRNA knockdown of β-arrestin-1 and β-arrestin-2 in HEK-293 cells expressing the OXTR, we demonstrated oxytocin-mediated MAPK signaling that was dependent on β-arrestin-1 and β-arrestin-2. Wild-type and β-arrestin-1 and β-arrestin-2 knockout mice receiving intravenous oxytocin also demonstrated oxytocin-mediated MAPK signaling that was dependent on β-arrestin-1 and β-arrestin-2. Finally, to test the significance of β-arrestin-mediated signaling from the OXTR, HEK-293 cells expressing the OXTR showed β-arrestin-dependent proliferation in a cell migration assay following oxytocin treatment. In conclusion, β-arrestin is a multifunctional scaffold protein that mediates both desensitization of the OXTR, leading to decreases in uterine contractility, and MAPK growth signaling following stimulation by oxytocin. The development of unique OXTR ligands that prevent receptor desensitization may be a novel approach in the treatment of adverse clinical events secondary to prolonged oxytocin therapy.

Indexed as

AnimalsArrestinsbeta-Arrestin 1beta-Arrestin 2beta-ArrestinsBlotting, WesternCell MovementCell ProliferationCells, CulturedFemaleHEK293 CellsHumansMiceMitogen-Activated Protein KinasesOxytocinReceptors, OxytocinARRB1 protein, humanArrb1 protein, mouseARRB2 protein, humanArrb2 protein, mouseArrestinsbeta-Arrestin 1beta-Arrestin 2beta-ArrestinsMitogen-Activated Protein KinasesOxytocinReceptors, OxytocinRNA, Small Interfering

Identifiers

PMID21139074
PMCPMC3064008
OpenAlexW2071651895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.